LMX 4% OTC
Generic Name and Formulations:
Lidocaine 4%; crm.
Ferndale Laboratories, Inc.
Indications for LMX 4%:
Topical anesthetic for minor wounds, burns, abrasions, insect bites, or pretreatment before injections, minor procedures.
Adults and Children:
Use occlusive dressing for young children or if cream may be disturbed. Clean area with mild soap; do not use alcohol or acetone. <2yrs: individualize. ≥2yrs: massage small amount of cream into skin, then completely cover affected area; leave on for 30–60 minutes (may add more cream); remove.
Not for use near tympanic membrane or on broken skin. Avoid eyes, mucous membranes, ingestion (esp. children or pets), application to large areas, and using for longer than recommended time. Pregnancy. Nursing mothers.
Irritation, pruritus, erythema, rash, systemic effects.
Crm 5g—1, 5
Crm 5g—1 (w. 2 dressings)
Crm 5g—5 (w. 10 dressings)
Crm 15g, 30g—1
Neurology Advisor Articles
- Excess Abdominal Obesity Linked to Severe Disability in Multiple Sclerosis
- Change in Dietary Patterns Over 5 Years in Early Multiple Sclerosis
- Biobank Data Suggest Vitamin D Reduces Risk for Multiple Sclerosis
- High-Dose Biotin May Be an Effective Treatment for Progressive MS
- Poor Functional Outcomes Tied to Depressive Symptoms in Multiple Sclerosis
- Managing Status Epilepticus in Palliative Care: Accounting for Patient and Family Experience
- Oxygen Desaturation Index Predicts AFib Risk in Ischemic Stroke
- Opioid Use Down With 'Enhanced Recovery After Surgery' Program
- Popular Heroin Inhalation Method Tied to Leukoencephalopathy
- Erenumab Superior to Placebo for Reducing Migraine Disability, Improving HRQoL